Two Sigma Advisers’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34M | Buy |
1,985,734
+1,709,400
| +619% | +$29.2M | 0.07% | 243 |
|
|
2025
Q1 | $17.6M | Buy |
+276,334
| New | +$17.6M | 0.04% | 363 |
|
|
2024
Q4 | – | Sell |
-128,034
| Closed | -$16M | – | 2521 |
|
|
2024
Q3 | $16M | Sell |
128,034
-478,800
| -79% | -$59.8M | 0.04% | 366 |
|
|
2024
Q2 | $95.9M | Sell |
606,834
-54,500
| -8% | -$8.61M | 0.21% | 97 |
|
|
2024
Q1 | $85.6M | Sell |
661,334
-44,800
| -6% | -$5.8M | 0.2% | 110 |
|
|
2023
Q4 | $68.1M | Sell |
706,134
-314,800
| -31% | -$30.4M | 0.16% | 136 |
|
|
2023
Q3 | $124M | Sell |
1,020,934
-238,500
| -19% | -$28.9M | 0.32% | 75 |
|
|
2023
Q2 | $144M | Buy |
1,259,434
+83,700
| +7% | +$9.59M | 0.37% | 75 |
|
|
2023
Q1 | $162M | Buy |
1,175,734
+566,100
| +93% | +$78M | 0.42% | 60 |
|
|
2022
Q4 | $79M | Buy |
609,634
+75,200
| +14% | +$9.74M | 0.22% | 100 |
|
|
2022
Q3 | $59.1M | Buy |
534,434
+256,000
| +92% | +$28.3M | 0.17% | 142 |
|
|
2022
Q2 | $20.9M | Sell |
278,434
-60,900
| -18% | -$4.56M | 0.06% | 318 |
|
|
2022
Q1 | $26.5M | Sell |
339,334
-117,100
| -26% | -$9.15M | 0.07% | 262 |
|
|
2021
Q4 | $41.1M | Buy |
+456,434
| New | +$41.1M | 0.1% | 178 |
|
|
2018
Q4 | – | Sell |
-17,792
| Closed | -$2.87M | – | 2450 |
|
|
2018
Q3 | $2.87M | Sell |
17,792
-67,900
| -79% | -$11M | 0.01% | 1054 |
|
|
2018
Q2 | $11.3M | Buy |
85,692
+48,834
| +132% | +$6.46M | 0.03% | 545 |
|
|
2018
Q1 | $2.73M | Buy |
+36,858
| New | +$2.73M | 0.01% | 1096 |
|
|
2016
Q4 | – | Sell |
-5,366
| Closed | -$330K | – | 2448 |
|
|
2016
Q3 | $330K | Buy |
+5,366
| New | +$330K | ﹤0.01% | 1850 |
|
|
2015
Q4 | – | Sell |
-28,166
| Closed | -$904K | – | 2012 |
|
|
2015
Q3 | $904K | Buy |
+28,166
| New | +$904K | 0.01% | 1047 |
|